# Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression

> **NCT06936046** · PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 200 (estimated)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** Dual antibody A
- **DRUG:** Dual antibody B
- **RADIATION:** Modified Stupp
- **DRUG:** Stupp protocol

## Key facts

- **NCT ID:** NCT06936046
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06936046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06936046, "Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06936046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*